Obesity
Avoiding ultra-processed foods makes it easier to control body weight
Adhering to a healthy diet without reducing the intake of ultra-processed foods misses the mark for losing weight.
Cardiometabolic Effects of Intermittent Fasting
In patients with metabolic syndrome, time-restricted eating significantly improves glucose metabolism.
Fat and Sugar: The Deadly Duo Behind Insulin Resistance
The presence of excess fat, especially if it is located in the abdominal area, represents the main risk factor for developing insulin resistance and the pathologies that result from it.
The anti-inflammatory effects of fermented foods
Several studies report that fermented foods have positive effects on the gut microbiota and reduce inflammation, a major risk factor for all chronic diseases.
Slowing down aging, a new concept for the prevention of all chronic diseases
Age is an important risk factor for all chronic diseases, implying that finding ways to slow down aging could simultaneously delay the onset of all these diseases and significantly improve healthy life expectancy.
Cardiovascular benefits associated with body weight loss
The results of clinical studies on new anti-obesity drugs confirm that significant body weight loss is associated with a reduced risk of cardiovascular disease.
Emulsifiers: Food additives that increase the risk of cardiovascular disease?
High consumption of certain emulsifiers widely used in the manufacture of ultra-processed foods is associated with an increased risk of cardiovascular disease.
Preventing cardiovascular disease also means preventing cancer!
One study reports that people who have cardiovascular disease are at much higher risk of developing several types of cancers in the years that follow.
Akkermansia muciniphila: An essential bacterium for maintaining good health
Akkermansia muciniphila, a bacterium that colonizes the mucus layer of the intestinal wall, contributes to the maintenance of this protective layer and generates metabolites that have several beneficial effects on metabolism and immunity.
Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity
Initially developed to treat patients with type 2 diabetes, these drugs also cause significant weight loss and are establishing themselves as the first truly effective pharmacological treatments for obesity.